Philipp Eller
Impact in
- Nephrology top 2%
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 13
- COVID-19 Clinical Research Studies 4
- Epidemiology 20
- Fungal Infections and Studies 5
- Sepsis Diagnosis and Treatment 5
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Kathrin Eller (30 shared papers)Alexander R. Rosenkranz (25 shared papers)Marianne Brodmann (19 shared papers)Gerald Hackl (26 shared papers)Franz Hafner (12 shared papers)Thomas Gary (13 shared papers)Alexander H. Kirsch (17 shared papers)Alexander C. Reisinger (31 shared papers)
- Journals
- PLoS ONE (4 papers)American Journal Of Pathology (3 papers)Medicine (3 papers)International Journal of Molecular Sciences (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Philipp Eller
91 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 110
- Nephrology 193
- Infectious Diseases 313
- Endocrinology, Diabetes and Metabolism 212
- Internal Medicine 40
- Applied Microbiology and Biotechnology 22
Countries citing papers authored by Philipp Eller
This map shows the geographic impact of Philipp Eller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Eller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Eller more than expected).
Fields of papers citing papers by Philipp Eller
This network shows the impact of papers produced by Philipp Eller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Eller. The network helps show where Philipp Eller may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Eller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 282 | |
| 2 | 2013 | 228 | |
| 3 | 2012 | 170 | |
| 4 | 2020 | 80 | |
| 5 | 2021 | 74 | |
| 6 | 2021 | 70 | |
| 7 | 2013 | 63 | |
| 8 | 2015 | 60 | |
| 9 | 2019 | 56 | |
| 10 | 2019 | 50 | |
| 11 | 2007 | 50 | |
| 12 | 2000 | 47 | |
| 13 | 2016 | 45 | |
| 14 | 2018 | 41 | |
| 15 | 2014 | 35 | |
| 16 | 2016 | 31 | |
| 17 | 2021 | 26 | |
| 18 | 2022 | 25 | |
| 19 | 2011 | 25 | |
| 20 | 2021 | 23 |
About Philipp Eller
Philipp Eller is a scholar working on Infectious Diseases, Epidemiology, Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 94 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (5 papers), Sepsis Diagnosis and Treatment (5 papers), Parathyroid Disorders and Treatments (5 papers), Vasculitis and related conditions (4 papers), Mechanical Circulatory Support Devices (4 papers), COVID-19 Clinical Research Studies (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). The work is most often cited by research in Nephrology (193 citations), Infectious Diseases (313 citations), Endocrinology, Diabetes and Metabolism (212 citations), Internal Medicine (40 citations) and Applied Microbiology and Biotechnology (22 citations). Philipp Eller has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Kathrin Eller, Alexander R. Rosenkranz, Marianne Brodmann, Gerald Hackl, Franz Hafner, Thomas Gary, Alexander H. Kirsch, Alexander C. Reisinger, Martin Pichler and Klara Belaj. Their work appears in journals such as PLoS ONE, American Journal Of Pathology, Medicine, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.